NASHNET Presents Innovative White Paper on Utilizing Biomarkers to Diagnose and Stage NAFLD/NASH

NEW YORK, June 27, 2023 — NASHNET, a Kinetix Group network of excellence dedicated to advancing care pathways for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), announced the release of an innovative white paper. The paper is titled Biomarkers for Diagnosing and Staging Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Current Perspectives and Potential Future Applications.